| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Ribosomal protein S6 kinase beta-1, 70 kDa ribosomal protein S6 kinase 1, P70S6K1, p70-S6K 1, Ribosomal protein S6 kinase I, Serine/threonine-protein kinase 14A, p70 ribosomal S6 kinase alpha, p70 S6 kinase alpha, p70 S6K-alpha, p70 S6KA, RPS6KB1, STK14A |
| Antigen | |
| Clonality | |
| Conjugate | |
| Form | Liquid |
| Host | |
| Immunogen | A synthesized peptide derived from human Phospho-RPS6KB1 (T421+S424) |
| Isotype | |
| Product Type | |
| Reactivity | |
| Source | This product is a recombinant monoclonal antibody expressed in HEK293F cells. |
| Storage | |
| Target | |
| UniProt # |
Product Overview
Primary AntibodyThis antibody targets RPS6KB1 and was raised against a recombinant protein immunogen.
Validated Applications
| Application | Recommended Dilution |
|---|---|
| ELISA | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
| Western Blot (WB) | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
| Immunofluorescence (IF) | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
| Immunoprecipitation (IP) | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
Antibody Specifications
| Target | RPS6KB1 |
|---|---|
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Conjugate | Unconjugated |
| Reactivity | Human |
| Purification | Affinity Purification |
| Antigen / Immunogen | A synthesized peptide derived from human Phospho-RPS6KB1 (T421+S424) |
| Clone Number | 3B6 |
| Production | This product is a recombinant monoclonal antibody expressed in HEK293F cells. |
| Form | Liquid |
| Storage Buffer | PBS, 150mM NaCl, 50% Glycerol, 0.05% BSA, 0.02% Sodium Azide, pH 7.4. |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
Alternative Names
Ribosomal protein S6 kinase beta-1, 70 kDa ribosomal protein S6 kinase 1, P70S6K1, p70-S6K 1, Ribosomal protein S6 kinase I, Serine/threonine-protein kinase 14A, p70 ribosomal S6 kinase alpha, p70 S6 kinase alpha, p70 S6K-alpha, p70 S6KA, RPS6KB1, STK14A
Safety & Handling
| Target | RPS6KB1 |
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Conjugate | Unconjugated |
| Reactivity | Human |
| Purification | Affinity Purification |
| Antigen/Immunogen | A synthesized peptide derived from human Phospho-RPS6KB1 (T421+S424) |
| Clone Number | 3B6 |
| Production | This product is a recombinant monoclonal antibody expressed in HEK293F cells. |
| Form | Liquid |
| Storage Buffer | PBS, 150mM NaCl, 50% Glycerol, 0.05% BSA, 0.02% Sodium Azide, pH 7.4. |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
Dilutions are starting recommendations. Titration is advised for each system.
| Application | Recommended Dilution |
|---|---|
| ELISA | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
| Western Blot (WB) | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
| Immunofluorescence (IF) | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
| Immunoprecipitation (IP) | WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
Immunogen: A synthesized peptide derived from human Phospho-RPS6KB1 (T421+S424)
Antigen Species: Human
Alternative Names
Ribosomal protein S6 kinase beta-1, 70 kDa ribosomal protein S6 kinase 1, P70S6K1, p70-S6K 1, Ribosomal protein S6 kinase I, Serine/threonine-protein kinase 14A, p70 ribosomal S6 kinase alpha, p70 S6 kinase alpha, p70 S6K-alpha, p70 S6KA, RPS6KB1, STK14A
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
